ReviewESMO gastrointestinal oncology2025

Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.

M Fakih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.